WISP1 Is a Novel Adipokine Linked to Inflammation in Obesity
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
WISP1 (Wnt1-inducible signaling pathway protein-1, also known as CCN4) is a member of the secreted extracellular matrix–associated proteins of the CCN family and a target gene of the Wingless-type (WNT) signaling pathway. Growing evidence links the WNT signaling pathway to the regulation of adipogenesis and low-grade inflammation in obesity. We aimed to validate WISP1 as a novel adipokine. Human adipocyte differentiation was associated with increased WISP1 expression and secretion. Stimulation of human macrophages with WISP1 led to a proinflammatory response. Circulating WISP1 and WISP1 subcutaneous adipose tissue expression were regulated by weight changes in humans and mice. WISP1 expression in visceral and subcutaneous fat tissue was associated with markers of insulin resistance and inflammation in glucose-tolerant subjects. In patients with nonalcoholic fatty liver disease, we found no correlation among disease activity score, liver fat content, and WISP1 expression. Insulin regulated WISP1 expression in adipocytes in vitro but had no acute effect on WISP1 gene expression in subcutaneous fat tissue in overweight subjects who had undergone hyperinsulinemic clamp experiments. The data suggest that WISP1 may play a role in linking obesity to inflammation and insulin resistance and could be a novel therapeutic target for obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807 · cited 3×
“Study I was approved by the ethics committee of the University of Leipzig, Germany and studies II-IV were approved by the ethics committees of (1) Potsdam University, Potsdam, Germany, (2) State Medical Association of Brandenburg, Germany and (3) Charité University Medicine, Berlin, Germany.”
InfluentialOverweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613 · cited 1×
“Central obesity and metabolic syndrome are independent risk factors for type 2 diabetes, cancer, nonalcoholic fatty liver disease (NAFLD), and an insulin-resistant state (1,2).”
BackgroundDynamics of fat cell turnover in humans
Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Näslund, E., Britton, T., et al. (2008) · Nature · doi:10.1038/nature06902 · Cited by 2,357 · cited 1×
“Although human white adipose tissue displays a high adipocyte turnover, the total number of adipocytes in adults remains constant even after weight reduction (27).”
BackgroundInflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319 · cited 1×
“Over the past decade, a unifying mechanism behind the pathogenesis of obesity-associated diseases has given birth to the concept of “meta-inflammation,” which describes the chronic low-grade inflammatory response to obesity (3).”
BackgroundWnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors
Gordon, M. D., & Nusse, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600015200 · Cited by 1,333
Dmitrieva, R. I., Minullina, I. R., Bilibina, A. A., Tarasova, O. V., Anisimov, S. V., & Zaritskey, A. Y. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18858 · Cited by 195 · cited 1×
“Human mesenchymal stem cells were isolated from abdominal SAT samples (25) and differentiated into mature adipocytes in DMEM-F12 supplemented with 500 mmol/L 3-isobutyl-1-methylxanthine, 25 nmol/L dexamethasone, 0.”
MethodSelf-citationGögebakan, Ö., Kohl, A., Osterhoff, M. A., van Baak, M. A., Jebb, S. A., Papadaki, A., Martinez, J. A., Handjieva-Darlenska, T., Hlavaty, P., Weickert, M. O., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.033274 · Cited by 180 · cited 1×
“A detailed description of the study design has been previously published (22).”
BackgroundSelf-citationCross-talk between Insulin and Wnt Signaling in Preadipocytes
Palsgaard, J., Emanuelli, B., Winnay, J. N., Sumara, G., Karsenty, G., & Kahn, C. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337048 · Cited by 98
Cited by
Lukjanenko, L., Karaz, S., Stuelsatz, P., Gurriaran-Rodriguez, U., Michaud, J., Dammone, G., Sizzano, F., Mashinchian, O., Ancel, S., Migliavacca, E., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2018.12.014 · Cited by 374
Rodríguez, A., Ezquerro, S., Méndez-Giménez, L., Becerril, S., & Frühbeck, G. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2015 · Cited by 282
Recinella, L., Orlando, G., Ferrante, C., Chiavaroli, A., Brunetti, L., & Leone, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.578966 · Cited by 261
Adipose tissue: an endocrine organ playing a role in metabolic regulation
Booth, A., Magnuson, A., Fouts, J., & Foster, M. T. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0073 · Cited by 208
Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation
Barchetta, I., Cimini, F. A., Ciccarelli, G., Baroni, M. G., & Cavallo, M. G. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01052-3 · Cited by 77
Metadata
- Authors
- Murahovschi, V., Pivovarova, O., Ilkavets, I., Dmitrieva, R. M., Döcke, S., Keyhani-Nejad, F., Gögebakan, Ö., Osterhoff, M., Kemper, M., Hornemann, S., Markova, M., Klöting, N., Stockmann, M., Weickert, M. O., Lamounier-Zepter, V., Neuhaus, P., Konradi, A., Dooley, S., von Loeffelholz, C., Blüher, M., Pfeiffer, A. F. H., & Rudovich, N.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-10-03
- Volume
- 64
- Issue
- 3
- Pages
- 856-866
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2101492172
- Cited by
- 130
- References
- 9
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.